EWEdwards Lifesciences Corp

NYSE edwards.com


$ 86.44 $ 1.76 (2.08 %)    

Tuesday, 14-May-2024 15:59:54 EDT
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 86.46
$ 85.76
$ 0.00 x 0
$ 0.00 x 0
$ 85.17 - $ 86.53
$ 60.57 - $ 96.12
2,119,569
na
52.23B
$ 1.16
$ 36.94
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-29-2024 03-31-2024 10-Q
2 02-12-2024 12-31-2023 10-K
3 10-27-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 04-28-2023 03-31-2023 10-Q
6 02-13-2023 12-31-2022 10-K
7 10-28-2022 09-30-2022 10-Q
8 07-29-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-K
11 10-29-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-K
15 10-26-2020 09-30-2020 10-Q
16 07-27-2020 06-30-2020 10-Q
17 04-28-2020 03-31-2020 10-Q
18 02-14-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 07-26-2019 06-30-2019 10-Q
21 04-26-2019 03-31-2019 10-Q
22 02-15-2019 12-31-2018 10-K
23 10-26-2018 09-30-2018 10-Q
24 07-27-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-29-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-20-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-04-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 indian-rival-meril-accuses-edwards-lifesciences-of-anti-competitive-behavior-in-eu-antitrust-complaint

Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent act...

 deutsche-bank-upgrades-edwards-lifesciences-to-buy-raises-price-target-to-103

Deutsche Bank analyst Pito Chickering upgrades Edwards Lifesciences (NYSE:EW) from Hold to Buy and raises the price target f...

 edwards-lifesciences--targeted-in-eu-antitrust-complaint-merils-complaint-singles-out-edwards-lifesciences-patent-practices-edwards-says-merils-eu-complaint-aims-to-circumvent-competition-national-court-decisions

- Reuters

 barclays-maintains-overweight-on-edwards-lifesciences-raises-price-target-to-101

Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $10...

 jim-cramer-these-airline-stocks-trade-wildly-edwards-lifesciences-at-the-right-level-to-buy

Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade...

 wells-fargo-maintains-overweight-on-edwards-lifesciences-raises-price-target-to-99

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target f...

 evercore-isi-group-maintains-in-line-on-edwards-lifesciences-lowers-price-target-to-89

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a In-Line and lowers the price target f...

 stifel-maintains-hold-on-edwards-lifesciences-raises-price-target-to-85

Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $83 to $85.

 piper-sandler-maintains-neutral-on-edwards-lifesciences-raises-price-target-to-88

Piper Sandler analyst Adam Maeder maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $...

 edwards-lifesciences-q1-2024-adj-eps-066-beats-064-estimate-sales-1598b-beat-1569b-estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.6...

 rbc-capital-maintains-outperform-on-edwards-lifesciences-raises-price-target-to-101

RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION